BNTX

Conviction 58HealthcareScan · Thu, Sep 24, 2026

BioNTech SE (BNTX) closed at $99.32 (+0.87%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 50, RS Rating 60, -16.8% from its 52-week high, +2.7% year to date. Sector: Healthcare · Biotechnology.

BNTX$99.32+0.87%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 878.46K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

BioNTech SEBiotechnologywww.biontech.de ↗

Price99.32

Change+0.87%

Gap-0.82%

Rel volume0.77×

Avg volume1.05M

Avg $ vol105.61M

SMA 20100.01

SMA 5097.79

SMA 20097.63

Price vs 50+1.57%

Price vs 200+1.73%

MA stackbullish

50/200 crossgolden · 1d

Supertrenddown · 107.52

RSI (14)50

MACD hist-0.28

MACD cross—

Stoch %K / %D42 / 43

ADX (14)16

+DI / −DI29 / 22

RSI divergence—

MACD divergence—

ATR %3.68%

ADR %2.86%

52w high119.34

52w low83.89

From 52w high-16.78%

Above 52w low+18.39%

New 52w highNo

SqueezeOff

Bollinger width14.45%

%B0.45

Donchian pos22.89%

Donchian high112.81

Donchian low95.32

AVWAP (52w high)97.33

vs AVWAP high+2.05%

AVWAP (52w low)95.48

vs AVWAP low+4.02%

OBV trendDown

Chaikin MF (20)-0.14

Today vs 20d0.77×

Avg vol (14d)878.46K

Avg vol (20d)1.05M

Avg $ vol (20d)105.61M

Market cap25.12B

RS Rating60 / 99

RS 3m (vs SPY)+5.86%

RS 6m (vs SPY)-4.93%

RS line new highNo

Trend template4/8

Technical rank60.9

1 week+0.67%

1 month-12.92%

3 months+10.36%

6 months+11.88%

1 year+1.07%

YTD+2.72%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target126.85

Target upside27.72%

Analyst ratingBuy

Institutional18.69%

Ent. value25.12B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out252.88M

Employees7.81K

ListedThu, Oct 10, 2019

Free float108.79M

Float %43.3%

Short interest2.3M

Days to cover1.0d

Short volume50.0%

Squeeze score16 / 100

Next earningsTue, Nov 3, 2026 · pre-mkt (40d)

EPS forecast$0.82 · 3 est

Last EPS vs est−$3.03 vs −$2.58

Last surprise-17.4% miss

Setup gradeC

Conviction58 / 100

Pattern quality—

Tech rank60.9 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance112.89

Support89.36

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in BNTX · 1 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Valerie Hoyle house · D · OR · traded 2025-08-07	Sell	$1K–$15K	2025-08-07	2025-09-12	PDF

Insider activity

SEC Form 4 transactions in BNTX · open-market 7 sells

Insider	Side	Shares	Value	Traded	Filed
Sahin Ugur Chief Executive Officer · Ordinary Shares · 2026-09-14	Sell	41K	$4.1M	2026-09-14	2026-09-14
Sahin Ugur Chief Executive Officer · Ordinary Shares · 2026-09-11	Sell	45K	$4.4M	2026-09-11	2026-09-14
Sahin Ugur Chief Executive Officer · Ordinary Shares · 2026-09-10	Sell	20.5K	$2.0M	2026-09-10	2026-09-11
Sahin Ugur Chief Executive Officer · Ordinary Shares · 2026-09-09	Sell	36K	$3.5M	2026-09-09	2026-09-09
Sahin Ugur Chief Executive Officer · Ordinary Shares · 2026-09-08	Sell	37K	$3.7M	2026-09-08	2026-09-09
Sahin Ugur Chief Executive Officer · Ordinary Shares · 2026-09-04	Sell	31.5K	$3.3M	2026-09-04	2026-09-08
Sahin Ugur Chief Executive Officer · Ordinary Shares · 2026-09-03	Sell	45K	$4.6M	2026-09-03	2026-09-08
Hanekamp Annemarie Chief Commercial Officer · Option (right to buy) · 2026-05-12	Grant	12.59K	$0	2026-05-12	2026-05-13
Poetting Sierk Chief Operating Officer · Performance Share Unit · 2026-05-12	Grant	10.07K	$0	2026-05-12	2026-05-13
Hanekamp Annemarie Chief Commercial Officer · Performance Share Unit · 2026-05-12	Grant	10.07K	$0	2026-05-12	2026-05-13

SEC filings

EDGAR filings in BNTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.